Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
20 Dec 2022
Letter to Shareholders End of Year Summary and 2023 Plans
01 Dec 2022
Final Director's Interest Notice - Dr. John Lambert
29 Nov 2022
ACCENT Trial Recruitment Progress
18 Nov 2022
Appendix 4D and Financial Report Half Year ended 30 Sep 22
07 Nov 2022
Amplia Appoints Dr Christopher Burns CEO & Managing Director
28 Oct 2022
Quarterly Activities and Cashflow Reports - Sep 2022 Qtr
10 Oct 2022
Notification regarding unquoted securities - ATX
03 Oct 2022
AMP886 Activity in Acute Myeloid Leukemia
14 Sep 2022
AACR Conference Presentation
12 Sep 2022
CEO Resignation
1
2
3
4
5
6
Next
